Clinical trials in follicular lymphoma

Trial Name

Description

Click for more information (external page)

GEN3013

Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non-Hodgkin lymphoma

Suitable for patients with B cell non-Hodgkin lymphoma which has come back after previous treatment

PETReA

A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymphoma

Suitable for patients who haven't yet received any treatment

GO29781

A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab.

Suitable for patients with lymphoma which has come back after previous treatment

GCT3013-02

A phase 1b/2 trial of a targeted treatment, epcoritamab, in combination with different chemotherapy regimens, in people with B-cell non-Hodgkin lymphoma.

CO41942

A phase 1b trial testing different combinations of targeted drugs in people with relapsed or refractory follicular lymphoma.

JNJ LYM1001

A phase 1 trial of a new treatment called JNJ-75348780 in people with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia.

CCS1477-02

A phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma.